About this trial
This study aims to evaluate prevalence of abnormal Pap smear among sexually active women of reproductive age attending sohag university hospital outpatient clinic.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Non pregnant sexually active women aged from 21 to 60 years old.
Patients who didn't have their pap smear done in last 3 years .
Patient who had previous abnormal pap smear and coming for follow up.
Disqualifiers
Women who were diagnosed cervical cancer that was treated.
Women who underwent total hysterectomy.
Women who are pregnant.
Patients whose pap smear was done in last 3 years with reassuring results.
Trial population
Non pregnant sexually active women aged from 21 to 60 years old.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Screening pap smear test
Other interventionThe patient put in dorsal lithotomy position and place the feet in stirrups or on foot rests . then, the physician will insert a cusco speculum into the vagina to hold vaginal wall open . The specimens will be collected as follows; firstly, the speculum will be inserted without lubricant. Any mucous, discharge or blood will be removed with dry cotton. A wooden spatula will be used for sampling ectocervix which will be rotated 360 degrees. For sampling endocervix, A brush or a swab will be rotated only 90 degrees as the circumferential bristles will be in contact with the entire surface the moment the brush is inserted. The samples will be applied to the slides which will be encoded and immediately fixed in 95% ethanol and the samples will be transferred to pathology department to be stained by the standard Papanicolaou stain
Treatment groups
Trial outcomes
Primary outcomes
number of abnormal pap smear among sexually active women of reproductive age attending sohag university hospital outpatient clinic.
to evaluate prevalence of abnormal Pap smear among sexually active women of reproductive age attending sohag university hospital outpatient clinic.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.